health canada semaglutide approves first generic for weight loss Health Canada approves generic Ozempic

Virta Health, with its telemedicine nutrition therapy program combined with GLP-1 treatment, has clinically demonstrated its ability to keep patients from weight gain following GLP-1 deprescription

National Osteoporosis Foundation

In total we collected 860,190 nuclei that passed standard quality metrics (Fig

Being protected inside a dry liposomal structure, glutathione keeps its integrity during digestive transit, which helps its optimal absorption

Retatrutide, also known as LY3437943, is an investigational drug developed by Eli Lilly and Company

Orforglipron, an oral small-molecule glp-1 receptor agonist, in early type 2 diabetes